Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Erickson

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 26, 1999
Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450D A Erickson, G Mather, W F Trager, et al.
The Journal of the Acoustical Society of America|May 1, 1981
The effects of noise upon human hearing sensitivity from 8000 to 20 000 HzS A Fausti, D A Erickson, R H Frey, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 23, 2009
Seven-month developmental outcomes of very low birth weight infants enrolled in a randomized controlled trial of delayed versus immediate cord clampingJ S Mercer, B R Vohr, D A Erickson-Owens, et al.
The Journal of the Acoustical Society of America|December 1, 1979
A system for evaluating auditory function from 8000--20 000 HzS A Fausti, R H Frey, D A Erickson, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|December 9, 2016
Effects of delayed cord clamping on residual placental blood volume, hemoglobin and bilirubin levels in term infants: a randomized controlled trialJ S Mercer, D A Erickson-Owens, J Collins, et al.
Journal of Medicinal Chemistry|July 31, 1998
Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinonesC L Cywin, J M Klunder, M Hoermann, et al.
Journal of Medicinal Chemistry|July 31, 1998
Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymesJ M Klunder, M Hoermann, C L Cywin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 26, 1999
Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450D A Erickson, G Mather, W F Trager, et al.
The Journal of the Acoustical Society of America|May 1, 1981
The effects of noise upon human hearing sensitivity from 8000 to 20 000 HzS A Fausti, D A Erickson, R H Frey, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|October 23, 2009
Seven-month developmental outcomes of very low birth weight infants enrolled in a randomized controlled trial of delayed versus immediate cord clampingJ S Mercer, B R Vohr, D A Erickson-Owens, et al.
The Journal of the Acoustical Society of America|December 1, 1979
A system for evaluating auditory function from 8000--20 000 HzS A Fausti, R H Frey, D A Erickson, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|December 9, 2016
Effects of delayed cord clamping on residual placental blood volume, hemoglobin and bilirubin levels in term infants: a randomized controlled trialJ S Mercer, D A Erickson-Owens, J Collins, et al.
Journal of Medicinal Chemistry|July 31, 1998
Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinonesC L Cywin, J M Klunder, M Hoermann, et al.
Journal of Medicinal Chemistry|July 31, 1998
Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymesJ M Klunder, M Hoermann, C L Cywin, et al.
Pageof 2